SCHEMBL8400925

SCHEMBL8400925

CCNC(=N)N(CC)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
GLA P06280 1/20 0.53
TSHR P16473 1/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
TP53 P04637 2/20 0.42
HPGD P15428 2/20 0.42
HDAC1 Q13547 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10728982 0.86 L3MBTL1 (0.49) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11842165 0.83 ALDH1A1 (0.55) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL7787793 0.80 KMT2A (0.65) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL18762979 0.79 MEN1 (0.57) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL1520370 0.79 MEN1 (0.66) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL7987611 0.78 L3MBTL1 (0.73) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL965733 0.78 MEN1 (0.67) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL2835777 0.76 ALDH1A1 (0.61) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL6858007 0.75 ALDH1A1 (0.59) ALDH1A1GLATSHRMEN1KMT2A
SCHEMBL11805974 0.75 ALDH1A1 (0.50) ALDH1A1GLATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0918460-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-06-02 EP disclosed
WO-1998004131-A1 METHODS OF TREATMENT OF EYE TRAUMA AND DISORDERS CAMBRIDGE NEUROSCIENCE, INC. (US) 1998-02-05 WO disclosed